Compare GSBC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GSBC | BVS |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 859.1M | 929.6M |
| IPO Year | 1996 | 2016 |
| Metric | GSBC | BVS |
|---|---|---|
| Price | $78.11 | $13.99 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $65.00 | $14.00 |
| AVG Volume (30 Days) | 61.6K | ★ 443.5K |
| Earning Date | 04-15-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | 17.68 | ★ 163.46 |
| EPS | ★ 2.99 | 0.52 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | $2.56 | $7.06 |
| P/E Ratio | ★ $26.08 | $26.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $53.76 | $6.37 |
| 52 Week High | $82.91 | $15.89 |
| Indicator | GSBC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 56.94 |
| Support Level | $77.24 | $13.44 |
| Resistance Level | $82.03 | $14.71 |
| Average True Range (ATR) | 1.28 | 0.44 |
| MACD | -0.15 | 0.07 |
| Stochastic Oscillator | 8.18 | 92.88 |
Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.